Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 Oct. 26];8(6):s465. Available from: https://skin.dermsquared.com/skin/article/view/3084